Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

recombinant transforming growth factor-beta-2

A recombinant polypeptide chemically identical to or similar to the endogenous cytokine transforming growth factor-beta-2 (TGF-beta-2). TGF-beta-2 modulates cell growth and immune function and may promote or inhibit tumor growth, depending on the tumor cell type. TGF-beta-2 may also suppress host immune system recognition of and/or response to tumor cells.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:glioblastoma-derived T-cell suppressor factor
transforming growth factor-beta 2
Abbreviation:rTGF-beta-2
Acronym:TGF-beta 2
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search